Edap Tms S.a. (EDAP)
EDAP Stock Price Chart
Explore Edap Tms S.a. interactive price chart. Choose custom timeframes to analyze EDAP price movements and trends.
EDAP Company Profile
Discover essential business fundamentals and corporate details for Edap Tms S.a. (EDAP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
1 Aug 1997
Employees
310.00
Website
https://www.edap-tms.comCEO
Ryan Rhodes
Description
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
EDAP Financial Timeline
Browse a chronological timeline of Edap Tms S.a. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.25, while revenue estimate is $15.05M.
Earnings released on 28 Aug 2025
EPS came in at -$0.17 surpassing the estimated -$0.18 by +5.56%, while revenue for the quarter reached $18.89M , beating expectations by +29.45%.
Earnings released on 15 May 2025
EPS came in at -$0.20 falling short of the estimated -$0.16 by -25.00%, while revenue for the quarter reached $14.86M , missing expectations by -10.45%.
Earnings released on 27 Mar 2025
EPS came in at -$0.05 surpassing the estimated -$0.11 by +54.55%, while revenue for the quarter reached $21.04M , beating expectations by +21.03%.
Earnings released on 7 Nov 2024
EPS came in at -$0.19 falling short of the estimated -$0.16 by -18.75%, while revenue for the quarter reached $14.37M , missing expectations by -31.02%.
Earnings released on 28 Aug 2024
EPS came in at -$0.18 falling short of the estimated -$0.14 by -28.57%, while revenue for the quarter reached $16.98M , missing expectations by -3.09%.
Earnings released on 16 May 2024
EPS came in at -$0.13 falling short of the estimated -$0.10 by -30.00%, while revenue for the quarter reached $16.11M , missing expectations by -6.07%.
Earnings released on 27 Mar 2024
EPS came in at -$0.15 falling short of the estimated -$0.05 by -229.09%, while revenue for the quarter reached $21.02M , beating expectations by +22.54%.
Earnings released on 9 Nov 2023
EPS came in at -$0.12 falling short of the estimated -$0.11 by -9.09%, while revenue for the quarter reached $12.38M , missing expectations by -30.87%.
Earnings released on 24 Aug 2023
EPS came in at -$0.14 falling short of the estimated -$0.05 by -178.33%, while revenue for the quarter reached $15.58M , missing expectations by -6.50%.
Earnings released on 17 May 2023
EPS came in at -$0.22 falling short of the estimated -$0.03 by -594.23%, while revenue for the quarter reached $16.09M , beating expectations by +7.67%.
Earnings released on 30 Mar 2023
EPS came in at -$0.14 falling short of the estimated -$0.00 by -2.81K%, while revenue for the quarter reached $16.93M , beating expectations by +0.42%.
Earnings released on 16 Nov 2022
EPS came in at $0.00 surpassing the estimated -$0.05 by +100.74%, while revenue for the quarter reached $11.96M , missing expectations by -1.97%.
Earnings released on 24 Aug 2022
EPS came in at $0.06 surpassing the estimated $0.02 by +267.87%, while revenue for the quarter reached $14.80M , beating expectations by +8.15%.
Earnings released on 17 May 2022
EPS came in at $0.01 surpassing the estimated $0.00 by +138.10%, while revenue for the quarter reached $14.38M , beating expectations by +4.97%.
Earnings released on 30 Mar 2022
EPS came in at $0.04 surpassing the estimated $0.01 by +232.50%, while revenue for the quarter reached $15.84M , missing expectations by -4.77%.
Earnings released on 17 Nov 2021
EPS came in at -$0.04 falling short of the estimated -$0.01 by -316.23%, while revenue for the quarter reached $10.96M , missing expectations by -20.37%.
Earnings released on 25 Aug 2021
EPS came in at -$0.02 falling short of the estimated -$0.01 by -199.85%, while revenue for the quarter reached $12.28M , missing expectations by -15.22%.
Earnings released on 11 May 2021
EPS came in at $0.03 falling short of the estimated $0.07 by -57.14%, while revenue for the quarter reached $12.12M , missing expectations by -45.11%.
Earnings released on 30 Mar 2021
EPS came in at $0.03 falling short of the estimated $0.10 by -70.00%, while revenue for the quarter reached $18.84M .
Earnings released on 18 Nov 2020
EPS came in at -$0.04 falling short of the estimated -$0.02 by -100.00%, while revenue for the quarter reached $11.08M , missing expectations by -0.99%.
EDAP Stock Performance
Access detailed EDAP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.